Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition capable of releasing asthenopia and preparation method thereof

A technology for relieving visual fatigue and composition, applied in the field of composition and its preparation with the function of relieving visual fatigue, capable of solving problems such as visual dysfunction, photoreceptor structural damage, abnormal electroretinogram, etc.

Inactive Publication Date: 2009-06-10
BEIJING INCREASEPHARM CORP LTD
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In vivo, decreased taurine concentrations in the retina lead to structural disruption of photoreceptors with severe visual dysfunction and electroretinogram abnormalities

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Get 200g of wolfberry fruit extract, 900g of mulberry fruit extract, 100g of chrysanthemum flower extract, 100g of taurine, and 300g of pearl powder, mix well, add 18000g of lactose, and make granules according to conventional methods.

Embodiment 2

[0023] Get 250g of wolfberry fruit extract, 940g of mulberry fruit extract, 150g of chrysanthemum flower extract, 110g of taurine, and 170g of pearl powder, mix well, add 1000g of dextrin, and make granules according to conventional methods.

Embodiment 3

[0025] Get 600g of wolfberry fruit extract, 1500g of mulberry fruit extract, 800g of chrysanthemum flower extract, 500g of taurine, and 100g of pearl powder, mix well, add 1500g of starch, and make tablets according to conventional methods.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a composition with asthenopia alleviation function and a preparation method of the same. The composition is prepared from raw materials of wolfberry extract, mulberry extract, taurine, chrysanthemum extract and pearl powder according to proper proportion and proper auxiliary materials, and can be prepared into any clinic acceptable dosage form such as tablet, capsule, particle, soft capsule and oral liquid.

Description

technical field [0001] The invention relates to a composition capable of alleviating visual fatigue and a preparation method thereof. Background technique [0002] The word asthenopia is derived from the Greek expression, which originally means "weak eye" (weak eyes). According to Duke-II der, visual fatigue includes "syndrome arising from the voluntary efforts of the visual apparatus to obtain clear vision with insufficient accommodation", and Suzumura defines visual fatigue as a group of subjective symptoms produced when working with the eyes. Syndrome of symptoms including blurred vision, headache, epiphora, stiff shoulders, and nausea. Most ophthalmologists now believe that the disease is based on the patient's conscious eye symptoms, and is a syndrome in which eye or systemic organic factors and mental (psychological) factors are intertwined. Therefore, it is often called eye fatigue syndrome and belongs to the category of psychosomatic medicine. [0003] Chrysanthem...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A23L1/29A23L1/28A23L1/48A61K36/815A61P27/02A23L33/00
Inventor 范利平张卫华
Owner BEIJING INCREASEPHARM CORP LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products